Nondiploid cancer cells: Stress, tolerance and therapeutic inspirations.

[1]  F. Pearl,et al.  Aneuploidy tolerance caused by BRG1 loss allows chromosome gains and recovery of fitness , 2022, Nature Communications.

[2]  Chun-Chia Huang,et al.  Assessment of Telomere Length and Mitochondrial DNA Copy Number in Granulosa Cells as Predictors of Aneuploidy Rate in Young Patients , 2022, Journal of clinical medicine.

[3]  D. Cimini,et al.  Whole-Genome Duplication Shapes the Aneuploidy Landscape of Human Cancers. , 2022, Cancer research.

[4]  Jin Zhu,et al.  Effects of aneuploidy on cell behaviour and function , 2022, Nature Reviews Molecular Cell Biology.

[5]  Martin H. Schaefer,et al.  Regulation of protein complex partners as a compensatory mechanism in aneuploid tumors , 2021, bioRxiv.

[6]  A. Mes-Masson,et al.  NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer , 2021, Oncogene.

[7]  A. Ciliberto,et al.  Epistasis, aneuploidy, and functional mutations underlie evolution of resistance to induced microtubule depolymerization , 2021, The EMBO journal.

[8]  Jason M. Sheltzer,et al.  Chromosomal instability and aneuploidy as causes of cancer drug resistance. , 2021, Trends in cancer.

[9]  A. Tolcher,et al.  A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation , 2021, Clinical Cancer Research.

[10]  Jun Yao,et al.  IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming , 2021, Oncogenesis.

[11]  Hailing Jin,et al.  Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes , 2021, Nature Communications.

[12]  H. Heng,et al.  ER Stress and Micronuclei Cluster: Stress Response Contributes to Genome Chaos in Cancer , 2021, Frontiers in Cell and Developmental Biology.

[13]  A. Pichlmair,et al.  Genotoxic stress in constitutive trisomies induces autophagy and the innate immune response via the cGAS-STING pathway , 2021, Communications biology.

[14]  M. Milán,et al.  Proteostasis failure and mitochondrial dysfunction leads to aneuploidy-induced senescence. , 2021, Developmental cell.

[15]  J. Irianto,et al.  Polyploid mitosis and depolyploidization promote chromosomal instability and tumor progression in a Notch-induced tumor model. , 2021, Developmental cell.

[16]  A. Amon,et al.  Aneuploid senescent cells activate NF‐κB to promote their immune clearance by NK cells , 2021, EMBO reports.

[17]  S. Lippman,et al.  Immune evasion in HPV− head and neck precancer–cancer transition is driven by an aneuploid switch involving chromosome 9p loss , 2021, Proceedings of the National Academy of Sciences.

[18]  P. Lu,et al.  Ceramide Synthase 6 Maximizes p53 Function to Prevent Progeny Formation from Polyploid Giant Cancer Cells , 2021, Cancers.

[19]  U. Ben-David,et al.  Relevance of aneuploidy for cancer therapies targeting the spindle assembly checkpoint and KIF18A , 2021, Molecular & cellular oncology.

[20]  Q. Song,et al.  DNA hypomethylation in tetraploid rice potentiates stress-responsive gene expression for salt tolerance , 2021, Proceedings of the National Academy of Sciences.

[21]  S. Horswell,et al.  Disruption of the MSL complex inhibits tumor maintenance by exacerbating chromosomal instability , 2021, Nature cell biology.

[22]  S. Sleijfer,et al.  Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases , 2021, Clinical Cancer Research.

[23]  P. Spellman,et al.  Proliferative polyploid cells give rise to tumors via ploidy reduction , 2021, Nature communications.

[24]  James M. McFarland,et al.  Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibition , 2021, Nature.

[25]  K. Kinzler,et al.  Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients with Barrett's Esophagus. , 2021, Gastroenterology.

[26]  Jason M. Sheltzer,et al.  Aneuploidy as a promoter and suppressor of malignant growth , 2021, Nature Reviews Cancer.

[27]  A. Onofre,et al.  Aneuploidy detection for diagnostic and prognostic use in premalignant and malignant lesions of the uterine cervix: A systematic review , 2020, Diagnostic cytopathology.

[28]  E. Dmitrovsky,et al.  A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers , 2020, Molecular Cancer Therapeutics.

[29]  E. Sikora,et al.  THERAPY-INDUCED POLYPLOIDIZATION AND SENESCENCE; COINCIDENCE OR INTERCONNECTION? , 2020, Seminars in cancer biology.

[30]  E. Seli,et al.  Shorter telomere length of white blood cells is associated with higher rates of aneuploidy among infertile women undergoing in vitro fertilization. , 2020, Fertility and sterility.

[31]  James M. McFarland,et al.  Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division , 2020, Proceedings of the National Academy of Sciences.

[32]  T. Cameron Waller,et al.  The unfolded protein response links tumor aneuploidy to local immune dysregulation , 2020, bioRxiv.

[33]  Qiang Sun,et al.  p53-dependent elimination of aneuploid mitotic offspring by entosis , 2020, Cell death and differentiation.

[34]  Mustafa Ergul,et al.  A specific inhibitor of polo-like kinase 1, GSK461364A, suppresses proliferation of Raji Burkitt's lymphoma cells through mediating cell cycle arrest, DNA damage, and apoptosis. , 2020, Chemico-biological interactions.

[35]  J. Kendall,et al.  Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies , 2020, bioRxiv.

[36]  Nicolai J. Birkbak,et al.  Pervasive chromosomal instability and karyotype order in tumour evolution , 2020, Nature.

[37]  Noah Dephoure,et al.  Consequences of aneuploidy in human fibroblasts with trisomy 21 , 2020, Proceedings of the National Academy of Sciences.

[38]  Joshua D. Campbell,et al.  Whole genome doubling confers unique genetic vulnerabilities on tumor cells , 2020, Nature.

[39]  M. Zernicka-Goetz,et al.  Autophagy-mediated apoptosis eliminates aneuploid cells in a mouse model of chromosome mosaicism , 2020, Nature Communications.

[40]  V. Naim,et al.  DNA Replication Stress and Chromosomal Instability: Dangerous Liaisons , 2020, Genes.

[41]  A. Levine.  p53: 800 million years of evolution and 40 years of discovery , 2020, Nature Reviews Cancer.

[42]  M. Dunham,et al.  The environmental stress response causes ribosome loss in aneuploid yeast cells , 2020, Proceedings of the National Academy of Sciences.

[43]  E. Koonin,et al.  Interplay between DNA damage repair and apoptosis shapes cancer evolution through aneuploidy and microsatellite instability , 2020, Nature Communications.

[44]  P. Lu,et al.  Tamoxifen is a candidate first‐in‐class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells—Unrecognized players in tumorigenesis , 2020, Cancer medicine.

[45]  Ping-Chih Ho,et al.  ER Stress Responses: An Emerging Modulator for Innate Immunity , 2020, Cells.

[46]  Angela E. Leek,et al.  Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution , 2020, Nature Genetics.

[47]  A. Koren,et al.  Molecular signatures of aneuploidy-driven adaptive evolution , 2020, Nature Communications.

[48]  Shidan Wang,et al.  Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity but Develop Fewer Tumors Following Chronic Liver Injury. , 2020, Gastroenterology.

[49]  Yue Huang,et al.  Genotoxins exaggerate the stressed state of aneuploid embryonic stem cells via activation of autophagy , 2019, Science China Life Sciences.

[50]  I. Rivera,et al.  Suppressing Aneuploidy-Associated Phenotypes Improves the Fitness of Trisomy 21 Cells , 2019, Cell reports.

[51]  R. Drapkin,et al.  Chromosomal instability and mTORC1 activation through PTEN loss contribute to proteotoxic stress in ovarian carcinoma. , 2019, Cancer research.

[52]  R. Bennett,et al.  Metabolism‐induced oxidative stress and DNA damage selectively trigger genome instability in polyploid fungal cells , 2019, The EMBO journal.

[53]  A. Amon,et al.  Context is everything: aneuploidy in cancer , 2019, Nature Reviews Genetics.

[54]  K. Komurov,et al.  Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion , 2019, Oncoimmunology.

[55]  C. Szabó,et al.  Overproduction of H2S, generated by CBS, inhibits mitochondrial Complex IV and suppresses oxidative phosphorylation in Down syndrome , 2019, Proceedings of the National Academy of Sciences.

[56]  S. Gregory,et al.  Co-Operation between Aneuploidy and Metabolic Changes in Driving Tumorigenesis , 2019, International journal of molecular sciences.

[57]  L. Carey,et al.  Overdosage of Balanced Protein Complexes Reduces Proliferation Rate in Aneuploid Cells. , 2019, Cell systems.

[58]  Yao-Xin Lin,et al.  Discovery of inhibitors of Aurora/PLK targets as anti-cancer agents. , 2019, Journal of medicinal chemistry.

[59]  G. Sun,et al.  Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases , 2019, BMC Cancer.

[60]  J. Harper,et al.  Protein aggregation mediates stoichiometry of protein complexes in aneuploid cells , 2019, Genes & development.

[61]  R. Medema,et al.  Degree and site of chromosomal instability define its oncogenic potential , 2019, Nature Communications.

[62]  A. van Oudenaarden,et al.  Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids , 2019, Nature Genetics.

[63]  P. Lu,et al.  Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis[S] , 2019, Journal of Lipid Research.

[64]  J. Zucman‐Rossi,et al.  Polyploidy spectrum: a new marker in HCC classification , 2019, Gut.

[65]  Sean X. Sun,et al.  Hypo-Osmotic-Like Stress Underlies General Cellular Defects of Aneuploidy , 2019, Nature.

[66]  Hongtao Yu,et al.  Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling , 2019, Nature Communications.

[67]  A. Duncan,et al.  The Polyploid State Restricts Hepatocyte Proliferation and Liver Regeneration in Mice , 2019, Hepatology.

[68]  Elizabeth R. Smith,et al.  Defective Nuclear Lamina in Aneuploidy and Carcinogenesis , 2018, Front. Oncol..

[69]  M. Hammer,et al.  Drug-induced aneuploidy and polyploidy is a mechanism of disease relapse in MYC/BCL2-addicted diffuse large B-cell lymphoma , 2018, Oncotarget.

[70]  B. Tarlow,et al.  Erratum: The Polyploid State Plays a Tumor-Suppressive Role in the Liver (Developmental Cell (2018) 44(4) (447–459.e5), (S1534580718300108) (10.1016/j.devcel.2018.01.010)) , 2018 .

[71]  Stephen S. Taylor,et al.  The p38α Stress Kinase Suppresses Aneuploidy Tolerance by Inhibiting Hif-1α , 2018, Cell reports.

[72]  L. Cantley,et al.  The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment , 2018, Cell.

[73]  R. Weichselbaum,et al.  Non‐canonical NF‐&kgr;B Antagonizes STING Sensor‐Mediated DNA Sensing in Radiotherapy , 2018, Immunity.

[74]  J. Sage,et al.  Beyond the Cell Cycle: Enhancing the Immune Surveillance of Tumors Via CDK4/6 Inhibition , 2018, Molecular Cancer Research.

[75]  B. Taylor,et al.  Genome doubling shapes the evolution and prognosis of advanced cancers , 2018, Nature Genetics.

[76]  G. Kroemer,et al.  Immune effectors responsible for the elimination of hyperploid cancer cells , 2018, Oncoimmunology.

[77]  G. Mills,et al.  PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness. , 2018, Cancer research.

[78]  L. Bubendorf,et al.  Quantitative proteomic and phosphoproteomic comparison of human colon cancer DLD-1 cells differing in ploidy and chromosome stability , 2018, Molecular biology of the cell.

[79]  V. Costanzo,et al.  SAMHD1 acts at stalled replication forks to prevent interferon induction , 2018, Nature.

[80]  Ashton C. Berger,et al.  Genomic and Functional Approaches to Understanding Cancer Aneuploidy. , 2018, Cancer cell.

[81]  E. Dmitrovsky,et al.  Engaging Anaphase Catastrophe Mechanisms to Eradicate Aneuploid Cancers , 2018, Molecular Cancer Therapeutics.

[82]  A. Stolzing,et al.  Cellular senescence: Immunosurveillance and future immunotherapy , 2018, Ageing Research Reviews.

[83]  Noah Dephoure,et al.  Serine-Dependent Sphingolipid Synthesis Is a Metabolic Liability of Aneuploid Cells. , 2017, Cell reports.

[84]  Samuel F. Bakhoum,et al.  Chromosomal instability drives metastasis through a cytosolic DNA response , 2017, Nature.

[85]  K. Kaestner,et al.  Cytoplasmic chromatin triggers inflammation in senescence and cancer , 2017, Nature.

[86]  M. Hemann,et al.  Aneuploid Cell Survival Relies upon Sphingolipid Homeostasis. , 2017, Cancer research.

[87]  Martin A. M. Reijns,et al.  cGAS surveillance of micronuclei links genome instability to innate immunity , 2017, Nature.

[88]  R. Hoffman,et al.  Imaging the Role of Multinucleate Pancreatic Cancer Cells and Cancer-Associated Fibroblasts in Peritoneal Metastasis in Mouse Models. , 2017, Anticancer research.

[89]  Angelika Amon,et al.  Chromosome Mis-segregation Generates Cell-Cycle-Arrested Cells with Complex Karyotypes that Are Eliminated by the Immune System. , 2017, Developmental cell.

[90]  Chang-Young Jang,et al.  TC Mps1 12, a novel Mps1 inhibitor, suppresses the growth of hepatocellular carcinoma cells via the accumulation of chromosomal instability , 2017, British journal of pharmacology.

[91]  Yi-Ping Hu,et al.  Hepatocyte polyploidization and its association with pathophysiological processes , 2017, Cell Death & Disease.

[92]  I. Mercado-uribe,et al.  Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells , 2017, Oncogene.

[93]  Angelika Amon,et al.  Single-chromosome Gains Commonly Function as Tumor Suppressors. , 2017, Cancer cell.

[94]  S. Elledge,et al.  Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy , 2017, Science.

[95]  Nicolai J. Birkbak,et al.  BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer , 2017, Cancer cell.

[96]  Karl J. Dykema,et al.  Chromosome instability drives phenotypic switching to metastasis , 2016, Proceedings of the National Academy of Sciences.

[97]  Jason M. Sheltzer,et al.  The pleiotropic deubiquitinase Ubp3 confers aneuploidy tolerance , 2016, Genes & development.

[98]  A. Giuliani,et al.  Somatic polyploidy is associated with the upregulation of c-MYC interacting genes and EMT-like signature , 2016, Oncotarget.

[99]  Shuhui Song,et al.  Aneuploid embryonic stem cells exhibit impaired differentiation and increased neoplastic potential , 2016, The EMBO journal.

[100]  Hongtao Yu,et al.  Mitotic Checkpoint Regulators Control Insulin Signaling and Metabolic Homeostasis , 2016, Cell.

[101]  M. Novelli,et al.  Revisiting tumour aneuploidy — the place of ploidy assessment in the molecular era , 2016, Nature Reviews Clinical Oncology.

[102]  Jørgen H Olsen,et al.  Low risk of solid tumors in persons with Down syndrome , 2016, Genetics in Medicine.

[103]  Shiv D. Kale,et al.  Selective advantage of trisomic human cells cultured in non-standard conditions , 2016, Scientific Reports.

[104]  B. Kerem,et al.  The presence of extra chromosomes leads to genomic instability , 2016, Nature Communications.

[105]  M. Zanetti,et al.  The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells , 2016, Oncogene.

[106]  Shiwu Zhang,et al.  The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer , 2015, Journal of experimental & clinical cancer research : CR.

[107]  M. Burkard,et al.  Identification of Selective Lead Compounds for Treatment of High-Ploidy Breast Cancer , 2015, Molecular Cancer Therapeutics.

[108]  M. O’Connor,et al.  Targeting the DNA Damage Response in Cancer. , 2015, Molecular cell.

[109]  Katarzyna Siudeja,et al.  Aneuploidy causes premature differentiation of neural and intestinal stem cells , 2015, Nature Communications.

[110]  E. White,et al.  Aneuploidy-induced cellular stresses limit autophagic degradation , 2015, Genes & development.

[111]  A. Amon,et al.  Short- and long-term effects of chromosome mis-segregation and aneuploidy , 2015, Nature Reviews Molecular Cell Biology.

[112]  K. Iwata,et al.  Aneuploidy generates proteotoxic stress and DNA damage concurrently with p53-mediated post-mitotic apoptosis in SAC-impaired cells , 2015, Nature Communications.

[113]  Nicolai J. Birkbak,et al.  Clonal status of actionable driver events and the timing of mutational processes in cancer evolution , 2015, Science Translational Medicine.

[114]  Jitendra Kumar Meena,et al.  Telomerase abrogates aneuploidy-induced telomere replication stress, senescence and cell depletion , 2015, The EMBO journal.

[115]  Takanori Kanai,et al.  Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids , 2015, Nature Medicine.

[116]  Z. Storchová,et al.  Causes and consequences of protein folding stress in aneuploid cells , 2015, Cell cycle.

[117]  R. Richards,et al.  Chromosomal instability causes sensitivity to metabolic stress , 2014, Oncogene.

[118]  Z. Storchová,et al.  HSF1 deficiency and impaired HSP90‐dependent protein folding are hallmarks of aneuploid human cells , 2014, The EMBO journal.

[119]  N. Benvenisty,et al.  Aneuploidy induces profound changes in gene expression, proliferation and tumorigenicity of human pluripotent stem cells , 2014, Nature Communications.

[120]  S. Gygi,et al.  Quantitative proteomic analysis reveals posttranslational responses to aneuploidy in yeast , 2014, eLife.

[121]  Z. Storchová,et al.  Unique features of the transcriptional response to model aneuploidy in human cells , 2014, BMC Genomics.

[122]  O. Kepp,et al.  Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention , 2014, Proceedings of the National Academy of Sciences.

[123]  Zoltan Szallasi,et al.  Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. , 2014, Cancer discovery.

[124]  S. Szymczak,et al.  Chromosomal Aneuploidy Affects the Global Proteome Equilibrium of Colorectal Cancer Cells , 2014, Analytical cellular pathology.

[125]  Jason M. Sheltzer,et al.  A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosis. , 2013, Cancer research.

[126]  T. Deerinck,et al.  Catastrophic Nuclear Envelope Collapse in Cancer Cell Micronuclei , 2013, Cell.

[127]  I. Mercado-uribe,et al.  Generation of erythroid cells from fibroblasts and cancer cells in vitro and in vivo. , 2013, Cancer letters.

[128]  L. Galluzzi,et al.  Immunological control of cell cycle aberrations for the avoidance of oncogenesis: the case of tetraploidy , 2013, Annals of the New York Academy of Sciences.

[129]  Lauren M. Zasadil,et al.  2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells. , 2013, Seminars in cell & developmental biology.

[130]  H. Clevers,et al.  Immunosurveillance against tetraploidization-induced colon tumorigenesis , 2013, Cell cycle.

[131]  A. Amon,et al.  Aneuploidy causes proteotoxic stress in yeast. , 2012, Genes & development.

[132]  Ming Li,et al.  An Immunosurveillance Mechanism Controls Cancer Cell Ploidy , 2012, Science.

[133]  D. Nižetić,et al.  Tumorigenesis in Down's syndrome: big lessons from a small chromosome , 2012, Nature Reviews Cancer.

[134]  M. Mann,et al.  Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells , 2012, Molecular Systems Biology.

[135]  Wei Zhang,et al.  Tetraploid cells from cytokinesis failure induce aneuploidy and spontaneous transformation of mouse ovarian surface epithelial cells , 2012, Cell cycle.

[136]  Maitreya J. Dunham,et al.  Transcriptional consequences of aneuploidy , 2012, Proceedings of the National Academy of Sciences.

[137]  H. Kestler,et al.  Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis. , 2012, The Journal of clinical investigation.

[138]  A. Schönthal,et al.  Role of BRCA1 in controlling mitotic arrest in ovarian cystadenoma cells , 2012, International journal of cancer.

[139]  S. Abdulkadir,et al.  Tumorigenic polyploid cells contain elevated ROS and ARE selectively targeted by antioxidant treatment , 2012, Journal of cellular physiology.

[140]  Qin Huang,et al.  Polyploid cells rewire DNA damage response networks to overcome replication stress-induced barriers for tumour progression , 2012, Nature Communications.

[141]  U. Moll,et al.  SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis , 2011, Cell Death and Differentiation.

[142]  Alison Stopeck,et al.  HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab , 2011, Clinical Cancer Research.

[143]  A. Godwin,et al.  Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer , 2011, BMC medicine.

[144]  A. Amon,et al.  Identification of Aneuploidy-Selective Antiproliferation Compounds , 2011, Cell.

[145]  D. Hartl,et al.  Misfolded proteins impose a dosage-dependent fitness cost and trigger a cytosolic unfolded protein response in yeast , 2010, Proceedings of the National Academy of Sciences.

[146]  Maitreya J. Dunham,et al.  Identification of Aneuploidy-Tolerating Mutations , 2010, Cell.

[147]  Anita Saraf,et al.  Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast , 2010, Nature.

[148]  A. Vinogradov,et al.  Somatic polyploidy promotes cell function under stress and energy depletion: evidence from tissue-specific mammal transcriptome , 2010, Functional & Integrative Genomics.

[149]  D. Nižetić,et al.  Tumour angiogenesis is reduced in the Tc1 mouse model of Down Syndrome , 2010, Nature.

[150]  S. Orkin,et al.  Perturbed hematopoiesis in the Tc1 mouse model of Down syndrome. , 2010, Blood.

[151]  Duane A. Compton,et al.  Proliferation of aneuploid human cells is limited by a p53-dependent mechanism , 2010, The Journal of cell biology.

[152]  E. Dmitrovsky,et al.  Targeting the Cyclin E-Cdk-2 Complex Represses Lung Cancer Growth by Triggering Anaphase Catastrophe , 2010, Clinical Cancer Research.

[153]  D. Cleveland,et al.  Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis , 2009, Nature Reviews Molecular Cell Biology.

[154]  S. Izraeli,et al.  Constitutional aneuploidy and cancer predisposition. , 2009, Human molecular genetics.

[155]  Jeannie T. Lee,et al.  X chromosome dosage compensation: how mammals keep the balance. , 2008, Annual review of genetics.

[156]  Angelika Amon,et al.  Aneuploidy Affects Proliferation and Spontaneous Immortalization in Mammalian Cells , 2008, Science.

[157]  Uri Tabori,et al.  Excessive genomic DNA copy number variation in the Li–Fraumeni cancer predisposition syndrome , 2008, Proceedings of the National Academy of Sciences.

[158]  Th. Boveri.  Concerning the Origin of Malignant Tumours by Theodor Boveri. Translated and annotated by Henry Harris , 2008, Journal of Cell Science.

[159]  Maitreya J. Dunham,et al.  Effects of Aneuploidy on Cellular Physiology and Cell Division in Haploid Yeast , 2007, Science.

[160]  B. Weaver,et al.  Does aneuploidy cause cancer? , 2006, Current opinion in cell biology.

[161]  Kendra S. Burbank,et al.  Genome-wide genetic analysis of polyploidy in yeast , 2006, Nature.

[162]  Z. Szallasi,et al.  A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers , 2006, Nature Genetics.

[163]  M. Gonsebatt,et al.  Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. , 2006, Carcinogenesis.

[164]  P. A. Hardy,et al.  Reappraisal of the Hansemann—Boveri hypothesis on the origin of tumors , 2005, Cell biology international.

[165]  David Pellman,et al.  Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells , 2005, Nature.

[166]  S. Lakhani,et al.  Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[167]  S. Duensing,et al.  Guilt by association? p53 and the development of aneuploidy in cancer. , 2005, Biochemical and biophysical research communications.

[168]  J. Sloan,et al.  Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[169]  J. Weinstein,et al.  Karyotypic complexity of the NCI-60 drug-screening panel. , 2003, Cancer research.

[170]  S. Horwitz,et al.  Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. , 2002, Cancer research.

[171]  G. Fink,et al.  Polyploids require Bik1 for kinetochore–microtubule attachment , 2001, The Journal of cell biology.

[172]  H. Malhi,et al.  Polyploidy associated with oxidative injury attenuates proliferative potential of cells. , 2001, Journal of cell science.

[173]  A. Vinogradov,et al.  Relationship of hepatocyte ploidy levels with body size and growth rate in mammals. , 2001, Genome.

[174]  D. Botstein,et al.  Genomic expression programs in the response of yeast cells to environmental changes. , 2000, Molecular biology of the cell.

[175]  Carissa A. Sanchez,et al.  17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[176]  P. Karran,et al.  DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. , 1995, Cancer research.

[177]  A. Vinogradov,et al.  Hepatocyte polyploidy and metabolism/life-history traits: hypotheses testing. , 1994, Journal of theoretical biology.

[178]  F. Solomon,et al.  Regulation of tubulin levels and microtubule assembly in Saccharomyces cerevisiae: consequences of altered tubulin gene copy number , 1990, Molecular and cellular biology.

[179]  Cristina Montagna,et al.  Aneuploidy acts both oncogenically and as a tumor suppressor. , 2007, Cancer cell.